Early research (Phase 1)Study completedNCT00004047What this trial is testingChemotherapy in Treating Patients Who Have Hematologic CancerWho this might be right forLeukemiaMyelodysplastic Syndromes Daiichi Sankyo
Testing effectiveness (Phase 2)Study completedNCT00365287What this trial is testingCombination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerWho this might be right forBreast CancerKidney CancerLeukemia+3 more Masonic Cancer Center, University of Minnesota 148
Early research (Phase 1)Study completedNCT01729806What this trial is testingIpilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell LymphomaWho this might be right forCD20 PositiveRecurrent B-Cell Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin Lymphoma National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT02952508What this trial is testingStudy of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in WaldenstromWho this might be right forWaldenstrom MacroglobulinemiaMultiple MyelomaChronic Lymphocytic Leukemia+6 more Cellectar Biosciences, Inc. 120
Testing effectiveness (Phase 2)Ended earlyNCT06561425What this trial is testingA Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin LymphomaWho this might be right forRelapsed/Refractory B-cell Non-Hodgkin LymphomaLymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell Lakefront Biotherapeutics NV 130
Testing effectiveness (Phase 2)Study completedNCT00918333What this trial is testingPanobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+25 more Mayo Clinic 124
Early research (Phase 1)Study completedNCT00030108What this trial is testingIxabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to TherapyWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+7 more National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)Study completedNCT01994850What this trial is testingBrentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma PatientsWho this might be right forCD30 Positive Primary Mediastinal Large B-cell LymphomaCD30-Positive Diffuse Large B-Cell LymphomaCD30-Positive Gray Zone Lymphoma Abramson Cancer Center at Penn Medicine 32
Early research (Phase 1)Study completedNCT00002818What this trial is testingHigh-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic MalignanciesWho this might be right forDrug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+1 more Virginia Commonwealth University 15
Early research (Phase 1)Study completedNCT00962507What this trial is testingPanobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaWho this might be right forLymphomaMultiple Myeloma and Plasma Cell Neoplasm City of Hope Medical Center 11
Testing effectiveness (Phase 2)Study completedNCT00057811What this trial is testingRituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or LymphomaWho this might be right forChildhood Burkitt LymphomaChildhood Diffuse Large Cell LymphomaChildhood Immunoblastic Large Cell Lymphoma+9 more Children's Oncology Group 97
Testing effectiveness (Phase 2)Study completedNCT01995669What this trial is testingLenalidomide and Obinutuzumab in Treating Patients With Relapsed Indolent Non-Hodgkin LymphomaWho this might be right forGrade 3a Follicular LymphomaRecurrent Follicular LymphomaRecurrent Grade 1 Follicular Lymphoma+7 more M.D. Anderson Cancer Center 66
Testing effectiveness (Phase 2)Study completedNCT00004105What this trial is testingCombination Chemotherapy in Treating Patients With Advanced CancerWho this might be right forLeukemiaLymphomaSarcoma+1 more NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT00379574What this trial is testingBortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCLWho this might be right forLymphoma, Large-Cell, DiffuseLymphoma, B-Cell Asan Medical Center 49
Early research (Phase 1)Study completedNCT00049400What this trial is testingS0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver DysfunctionWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific SWOG Cancer Research Network 78
Early research (Phase 1)Active Not RecruitingNCT02146924What this trial is testingCellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic LeukemiaRecurrent Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia City of Hope Medical Center 71
Large-scale testing (Phase 3)Study completedNCT00070382What this trial is testingDarbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for CancerWho this might be right forAnemiaLeukemiaLymphoma+4 more Jonsson Comprehensive Cancer Center 14
Not applicableStudy completedNCT00014482What this trial is testingMusic Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell TransplantationWho this might be right forAnxiety DisorderChronic Myeloproliferative DisordersDepression+4 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT03492125What this trial is testingThe Selective PKC-β Inhibitor MS- 553Who this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaAggressive Lymphoma MingSight Pharmaceuticals, Inc 60
Large-scale testing (Phase 3)Study completedNCT00005805What this trial is testingSt. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for CancerWho this might be right forChronic Myeloproliferative DisordersFatigueLeukemia+5 more Memorial Sloan Kettering Cancer Center